Navigating the rapidly expanding clinical biomarkers industry is an increasingly difficult task for today’s biopharmaceutical companies.
ApoCell’s deep scientific understanding of molecular profiling combined with our suite of fully integrated platform technologies enables us to support a wide array of biomarker monitoring strategies through our service portfolio.
ApoCell leverages proprietary technology to identify and analyze clinical biomarkers in order to fulfill our mission to help biopharmaceutical companies advance their lead drug candidates through clinical trials and into the hands of doctors. The outcome of these partnerships with biopharma is an economical understanding of investigational therapies and their impact on human biology that accelerates regulatory approval of new treatments for personalized medicine
It is our hope that the work we do with our partner organizations will lead to durable and long-lasting cures for these devastating diseases.